Jun Hua1, Paul G Unschuld, Russell L Margolis, Peter C M van Zijl, Christopher A Ross. 1. The Russell H. Morgan Department of Radiology and Radiological Science, Division of Magnetic Resonance Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Abstract
BACKGROUND: Neurovascular alterations have been implicated in the pathophysiology of Huntington's disease (HD). Because arterioles are most responsive to metabolic alterations, arteriolar cerebral blood volume (CBVa) is an important indicator of cerebrovascular regulation. The objective of this pilot study was to investigate potential neurovascular (CBVa ) abnormality in prodromal-HD patients and compare it with the widely used imaging marker: brain atrophy. METHODS: CBVa and brain volumes were measured with ultra-high-field (7.0-Telsa) magnetic resonance imaging in seven prodromal-HD patients and nine age-matched controls. RESULTS: Cortical CBVa was elevated significantly in prodromal-HD patients compared with controls (relative difference, 38.5%; effect size, 1.48). Significant correlations were found between CBVa in the frontal cortex and genetic measures. By contrast, no significant brain atrophy was detected in the prodromal-HD patients. CONCLUSIONS: CBVa may be abnormal in prodromal-HD, even before substantial brain atrophy occurs. Further investigation with a larger cohort and longitudinal follow-up is merited to determine whether CBVa could be used as a potential biomarker for clinical trials.
BACKGROUND: Neurovascular alterations have been implicated in the pathophysiology of Huntington's disease (HD). Because arterioles are most responsive to metabolic alterations, arteriolar cerebral blood volume (CBVa) is an important indicator of cerebrovascular regulation. The objective of this pilot study was to investigate potential neurovascular (CBVa ) abnormality in prodromal-HD patients and compare it with the widely used imaging marker: brain atrophy. METHODS: CBVa and brain volumes were measured with ultra-high-field (7.0-Telsa) magnetic resonance imaging in seven prodromal-HD patients and nine age-matched controls. RESULTS: Cortical CBVa was elevated significantly in prodromal-HD patients compared with controls (relative difference, 38.5%; effect size, 1.48). Significant correlations were found between CBVa in the frontal cortex and genetic measures. By contrast, no significant brain atrophy was detected in the prodromal-HD patients. CONCLUSIONS: CBVa may be abnormal in prodromal-HD, even before substantial brain atrophy occurs. Further investigation with a larger cohort and longitudinal follow-up is merited to determine whether CBVa could be used as a potential biomarker for clinical trials.
Authors: A Antonini; K L Leenders; R Spiegel; D Meier; P Vontobel; M Weigell-Weber; R Sanchez-Pernaute; J G de Yébenez; P Boesiger; A Weindl; R P Maguire Journal: Brain Date: 1996-12 Impact factor: 13.501
Authors: Simon J A van den Bogaard; Eve M Dumas; Tanka P Acharya; Hans Johnson; Douglas R Langbehn; Rachael I Scahill; Sarah J Tabrizi; Mark A van Buchem; Jeroen van der Grond; Raymund A C Roos Journal: J Neurol Date: 2010-10-09 Impact factor: 4.849
Authors: Egill Rostrup; Gitte M Knudsen; Ian Law; Søren Holm; Henrik B W Larsson; Olaf B Paulson Journal: Neuroimage Date: 2005-01-01 Impact factor: 6.556
Authors: J M G van Bergen; J Hua; P G Unschuld; I A L Lim; C K Jones; R L Margolis; C A Ross; P C M van Zijl; X Li Journal: AJNR Am J Neuroradiol Date: 2015-12-17 Impact factor: 3.825
Authors: X Li; D Wang; S Liao; L Guo; X Xiao; X Liu; Y Xu; J Hua; J J Pillai; Y Wu Journal: AJNR Am J Neuroradiol Date: 2020-03-05 Impact factor: 3.825
Authors: Jun Hua; SeungWook Lee; Nicholas I S Blair; Michael Wyss; Jiri M G van Bergen; Simon J Schreiner; Sonja M Kagerer; Sandra E Leh; Anton F Gietl; Valerie Treyer; Alfred Buck; Roger M Nitsch; Klaas P Pruessmann; Hanzhang Lu; Peter C M Van Zijl; Marilyn Albert; Christoph Hock; Paul G Unschuld Journal: Neurobiol Aging Date: 2019-01-10 Impact factor: 4.673
Authors: Jun Hua; Allison S Brandt; SeungWook Lee; Nicholas I S Blair; Yuankui Wu; Su Lui; Jaymin Patel; Andreia V Faria; Issel Anne L Lim; Paul G Unschuld; James J Pekar; Peter C M van Zijl; Christopher A Ross; Russell L Margolis Journal: Schizophr Bull Date: 2017-05-01 Impact factor: 9.306
Authors: Sarah Logan; Thiago Arzua; Scott G Canfield; Emily R Seminary; Samantha L Sison; Allison D Ebert; Xiaowen Bai Journal: Compr Physiol Date: 2019-03-14 Impact factor: 9.090
Authors: Yuankui Wu; Shruti Agarwal; Craig K Jones; Andrew G Webb; Peter C M van Zijl; Jun Hua; Jay J Pillai Journal: J Magn Reson Imaging Date: 2016-03-30 Impact factor: 4.813
Authors: Peter Klinkmueller; Martin Kronenbuerger; Xinyuan Miao; Jee Bang; Kia E Ultz; Adrian Paez; Xiaoyu Zhang; Wenzhen Duan; Russell L Margolis; Peter Cm van Zijl; Christopher A Ross; Jun Hua Journal: J Cereb Blood Flow Metab Date: 2020-08-17 Impact factor: 6.200